Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
Study NCT ID:
NCT01057251
Status:
COMPLETED
Last Update Posted:
2012-01-11
First Post:
2010-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Nebivolol in Patients With Systolic Stage 2 Hypertension
Sponsor:
Forest Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-26
First Submit QC Date:
None
Study First Post Date:
2010-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-06
Results First Submit QC Date:
None
Results First Post Date:
2012-01-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-06
Last Update Post Date:
2012-01-11
Last Update Post Date Type:
ESTIMATED